Budesonide improves QOL in Crohn's disease

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.360, 2002-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infliximab improves QOL in active and fistulising Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1346, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Budesonide for Crohn's disease

By Seow Cynthia H   Benchimol Eric I   Steinhart A Hillary   Griffiths Anne M   Otley Anthony R  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 971-979

Informa Healthcare

Access to resources Recommend Favorite

Salmeterol/fluticasone propionate improves QOL vs budesonide in asthma

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 393, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Budesonide (Entocort ™ EC) Capsules for Crohn’s Disease

By Edsbäcker Staffan  

Clinical Pharmacokinetics, Vol. 43, Iss. 12, 2004-01 ,pp. : 803-821

Adis International

Access to resources Recommend Favorite

Budesonide MRC offers new treatment option for Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite